ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Vaxxinity Inc

Vaxxinity Inc (VAXX)

0.7175
0.0285
(4.14%)
At close: March 28 04:00PM
0.72
0.031
( 4.50% )
After Hours: 06:28PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.72
Bid
0.70
Ask
0.72
Volume
340,324
0.67 Day's Range 0.73
0.56 52 Week Range 3.10
Market Cap
Previous Close
0.689
Open
0.67
Last Trade Time
19:12:48
Financial Volume
$ 239,172
VWAP
0.702777
Average Volume (3m)
415,735
Shares Outstanding
126,745,924
Dividend Yield
-
PE Ratio
-1.18
Earnings Per Share (EPS)
-0.59
Revenue
-
Net Profit
-75.22M

About Vaxxinity Inc

Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particul... Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Vaxxinity Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VAXX. The last closing price for Vaxxinity was $0.69. Over the last year, Vaxxinity shares have traded in a share price range of $ 0.56 to $ 3.10.

Vaxxinity currently has 126,745,924 shares outstanding. The market capitalization of Vaxxinity is $88.72 million. Vaxxinity has a price to earnings ratio (PE ratio) of -1.18.

VAXX Latest News

Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting

CAPE CANAVERAL, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced it will present...

Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates

CAPE CANAVERAL, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported...

Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024

LISBON, Portugal, March 07, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ: VAXX), a U.S. company pioneering the development of a new class of medicines, announced positive clinical data from...

Form 8-K - Current report

false 0001851657 NASDAQ 0001851657 2024-02-09 2024-02-09               UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published

Preclinical data published in the Journal of Lipid Research indicate VXX-401 is well-tolerated, with no safety signals observed, and robustly reduces LDL-C in cynomolgus monkeys. A Phase 1 trial...

Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024

CAPE CANAVERAL, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced it will present...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.022.857142857140.70.750.6222475320.67808782CS
4-0.087-10.7806691450.8071.050.565179330.74686558CS
12-0.078-9.774436090230.7981.050.564157350.71554876CS
26-0.78-521.51.50.563523830.81328914CS
52-1.4-66.03773584912.123.10.562700181.29365159CS
156-16.18-95.739644970416.922.770.563792254.11690067CS
260-16.18-95.739644970416.922.770.563792254.11690067CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLIQilian International Holding Group Ltd
$ 1.05
(52.20%)
2.85M
SBFMSunshine Biopharma Inc
$ 0.08
(32.23%)
26.19M
GRTXGalera Therapeutics Inc
$ 0.1731
(23.64%)
1.26M
MEDPMedpace Holdings Inc
$ 480.00
(18.77%)
1.41k
JSPRWJasper Therapeutics Inc
$ 0.2147
(17.97%)
600
XTKGX3 Holdings Company Ltd
$ 0.646
(-34.75%)
1.33M
VVOSVivos Therapeutics Inc
$ 3.60
(-25.47%)
86.98k
NVVENuvve Holding Corporation
$ 0.8625
(-21.59%)
138.49k
NDRAENDRA Life Sciences Inc
$ 0.4782
(-17.55%)
151.76k
XPONExpion360 Inc
$ 2.63
(-15.71%)
21.85k
SBFMSunshine Biopharma Inc
$ 0.08
(32.23%)
26.19M
CRKNCrown Electrokinetics Corporation
$ 0.0606
(1.17%)
7.37M
AAPLApple Inc
$ 171.28
(-0.12%)
3.57M
JAGXJaguar Health Inc
$ 0.0865
(-3.78%)
3.52M
GMDAGamida Cell Ltd
$ 0.0384
(6.37%)
3.39M

VAXX Discussion

View Posts
Awl416 Awl416 3 weeks ago
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
👍️0
81vette 81vette 4 weeks ago
not off hand,look on fda site,let us know,thanks!!!
👍️0
Monroe1 Monroe1 4 weeks ago
Any idea when the Phase 3 trial should finish?
🤡 1
Monksdream Monksdream 2 months ago
VAXX new 52 week low
👍️0
Monksdream Monksdream 5 months ago
VAXX under $2
👍️0
Monksdream Monksdream 6 months ago
VAXX new 52 week low
👍️0
Monksdream Monksdream 6 months ago
VAXX new 52 week low
👍️0
Monksdream Monksdream 6 months ago
VAXX under $2
👍️0
81vette 81vette 1 year ago
new and effective covid booster news coming is the thought,15 days of charting up and institutions loading while crickets are chirping
👍️0
81vette 81vette 1 year ago
https://ih.advfn.com/stock-market/NASDAQ/vaxxinity-VAXX/stock-news/89692734/vaxxinity-announces-positive-topline-pivotal-phase
👍️0
81vette 81vette 1 year ago
10Xs ave vol,blowing up scanners on this low float
👍️0
81vette 81vette 1 year ago
1M short ,squeeze babe !!! could be big news enroute with institutional buying like this
👍️0
81vette 81vette 1 year ago
biggest ever institution loading> Bank Of America 3.22 mm +3.20 mm +20179.3%
Vanguard 1.53 mm +1.48 mm +2676.7%
Marshall Wace 620.46 k +620.46 k NEW
Element Capital Management 376.89 k +376.89 k NEW
Creative Planning 277.52 k +277.52 k NEW
Renaissance Technologies 262.40 k +262.40 k NEW
Millennium Management 213.62 k +213.62 k NEW
Prime Movers Lab 17.85 mm -179.00 k -1.0%
Two Sigma Investments 128.52 k +128.52 k NEW
Ghisallo Capital Management 100.00 k +100.00 k NEW
👍️0
81vette 81vette 1 year ago
3Xs ave vol.,no news,dbl bottom,47% insider owned
👍️0
bandit007 bandit007 2 years ago
Loaded the crap out of this today
👍️0
bandit007 bandit007 2 years ago
Sexy looking bottom chart. Starting to move up now. $VAXX
👍️0
bandit007 bandit007 2 years ago
Stop losses below 3 got taken out. Should start moving up now
👍️0
bandit007 bandit007 2 years ago
Took a few down here
👍️0
TheFinalCD TheFinalCD 2 years ago
and on low volume
👍️0
bandit007 bandit007 2 years ago
Got vaxx? :)
👍️0
bandit007 bandit007 2 years ago
Breaking out
👍️0
bandit007 bandit007 2 years ago
On watch again
👍️0
bandit007 bandit007 2 years ago
I only hold a small position speculating here. Could be either gold or fool’s gold. Could pay off well if it ends up being the real deal. GL
👍️0
Deano361 Deano361 2 years ago
Trading nicely today now and not spikey
👍️0
Deano361 Deano361 2 years ago
I'm in this one now. Can't figure out if real or not. Some guy on Twits board claims it's a Nancy Pelosi fraud lol! I have no idea but if they truly figure out a Alz vaccine this will be like Moderna in the 100s
👍️0
bandit007 bandit007 2 years ago
Nice bounce back from the morning dip. $VAXX
👍️0
bandit007 bandit007 2 years ago
VAXX hod close?
👍️0
crudeoil24 crudeoil24 2 years ago
Nice trade! Maybe some news coming next week.
👍️0
TheFinalCD TheFinalCD 2 years ago
5.74 vol HALT down

only P1 news

I learned from crude to be careful with P1's I got burned on one that I lost $80,000

#HardLesson
👍️0
Awl416 Awl416 2 years ago
Impressive
👍️0
TheFinalCD TheFinalCD 2 years ago
GOT VAXX?
👍️0
crudeoil24 crudeoil24 2 years ago
VAXX halted > Nasdaq circuit breaker.

👍️0
crudeoil24 crudeoil24 2 years ago
Vaxxinity Shares Surge More Than 40% in Trading Debut After IPO VAXX
12:02 pm ET November 11, 2021 (Dow Jones)
👍️0
crudeoil24 crudeoil24 2 years ago
Vaxxinity, Inc. is a biotechnology company. The Company’s synthetic peptide vaccine platform (Vaxxine Platform) enables a new class of therapeutics that will improve the access to treatments for a range of indications. Its Vaxxine Platform is designed to connect the immune system to convert the body into its own drug factory, stimulating the production of antibodies with a therapeutic or protective effect. Its technology uses synthetic peptides to mimic and optimally combine biological epitopes in order to selectively activate the immune system, producing antibodies against only the desired targets, including self-antigens, making possible the safe and effective treatment of chronic diseases by vaccines. The modular and synthetic nature of its Vaxxine Platform provides significant in candidate development and has generated multiple product candidates that it is designing for many chronic diseases.
👍️0

Your Recent History

Delayed Upgrade Clock